Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Loffredo

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
British Journal of Haematology|April 27, 2013
Platelet size for distinguishing between inherited thrombocytopenias and immune thrombocytopenia: a multicentric, real life studyPatrizia Noris, Catherine Klersy, Paolo Gresele, et al.
Cardiovascular Diabetology|November 7, 2022
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trialFerdinando Carlo Sasso, Vittorio Simeon, Raffaele Galiero, et al.
Molecular Cytogenetics|October 3, 2012
Chromosome anomalies in bone marrow as primary cause of aplastic or hypoplastic conditions and peripheral cytopenia: disorders due to secondary impairment of RUNX1 and MPL genesCristina Marletta, Roberto Valli, Barbara Pressato, et al.
Thrombosis and Haemostasis|February 23, 2010
Heavy chain myosin 9-related disease (MYH9 -RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorderAnna Savoia, Daniela De Rocco, Emanuele Panza, et al.
Haematologica|September 22, 2011
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIbα (Bolzano mutation)Patrizia Noris, Silverio Perrotta, Roberta Bottega, et al.
Haematologica|July 2, 2016
Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemiaFederica Melazzini, Flavia Palombo, Alessandra Balduini, et al.
Blood|April 7, 2011
Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 familiesPatrizia Noris, Silverio Perrotta, Marco Seri, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 21, 2023
Mortality and risk factors of vaccinated and unvaccinated frail patients with COVID-19 treated with anti-SARS-CoV-2 monoclonal antibodies: A real-world studyRiccardo Nevola, Giovanni Feola, Rachele Ruocco, et al.
American Journal of Human Genetics|January 8, 2011
Mutations in the 5' UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2Tommaso Pippucci, Anna Savoia, Silverio Perrotta, et al.
Blood|July 4, 2014
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disordersPatrizia Noris, Ginevra Biino, Alessandro Pecci, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|April 27, 2013
Platelet size for distinguishing between inherited thrombocytopenias and immune thrombocytopenia: a multicentric, real life studyPatrizia Noris, Catherine Klersy, Paolo Gresele, et al.
Cardiovascular Diabetology|November 7, 2022
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trialFerdinando Carlo Sasso, Vittorio Simeon, Raffaele Galiero, et al.
Molecular Cytogenetics|October 3, 2012
Chromosome anomalies in bone marrow as primary cause of aplastic or hypoplastic conditions and peripheral cytopenia: disorders due to secondary impairment of RUNX1 and MPL genesCristina Marletta, Roberto Valli, Barbara Pressato, et al.
Thrombosis and Haemostasis|February 23, 2010
Heavy chain myosin 9-related disease (MYH9 -RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorderAnna Savoia, Daniela De Rocco, Emanuele Panza, et al.
Haematologica|September 22, 2011
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIbα (Bolzano mutation)Patrizia Noris, Silverio Perrotta, Roberta Bottega, et al.
Haematologica|July 2, 2016
Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemiaFederica Melazzini, Flavia Palombo, Alessandra Balduini, et al.
Blood|April 7, 2011
Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 familiesPatrizia Noris, Silverio Perrotta, Marco Seri, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 21, 2023
Mortality and risk factors of vaccinated and unvaccinated frail patients with COVID-19 treated with anti-SARS-CoV-2 monoclonal antibodies: A real-world studyRiccardo Nevola, Giovanni Feola, Rachele Ruocco, et al.
American Journal of Human Genetics|January 8, 2011
Mutations in the 5' UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2Tommaso Pippucci, Anna Savoia, Silverio Perrotta, et al.
Blood|July 4, 2014
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disordersPatrizia Noris, Ginevra Biino, Alessandro Pecci, et al.
Pageof 3